Loading companies…
Loading companies…
China · Healthtech · Hardware · AI
Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Strategic | CN¥500M | Alibaba — Role not disclosedFountainbridge Capital — Role not disclosedLilly Asia Ventures (LAV) — Role not disclosedOrbiMed — Role not disclosedOriza Seed — Role not disclosedQiming Venture Partners — Role not disclosedSource Code Capital — Role not disclosedTencent — Role not disclosed |